Company Analysis

CareDx, Inc. (CDNA)

Nasdaq: CDNA · Services-Medical Laboratories · Brisbane, CA · filing with the SEC since 2003
Grade5.2
◀ Past 4.9● Present 5.2▶ Future 5.6

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 25, 2026Feb 28, 2025Feb 28, 2024Feb 27, 2023Feb 24, 2022Feb 24, 2021Feb 28, 2020Mar 6, 2019Mar 22, 2018Apr 21, 2017
Revenue379,805,000333,785,000280,324,000321,793,000296,397,000192,194,000127,068,00076,569,00048,324,00040,631,000
For lenders
Net interest income·········-1,860,000
Cost of revenue······45,455,00032,987,00021,371,00010,240,000
Gross profit······81,613,00043,582,00026,953,000·
Research and development71,429,00072,510,000r82,421,000r90,388,00076,525,00048,941,00030,711,00014,514,00012,388,00012,385,000
Sales and marketing102,643,00081,975,000r84,062,000r96,027,00077,245,00053,858,00038,894,00021,670,00012,808,00011,166,000
General and administrative107,565,000125,139,000r118,838,000r100,397,00074,964,00048,806,00036,540,00022,976,000r20,093,000r20,725,000
Total operating expenses410,586,000293,020,000483,687,000399,024,000326,123,000214,722,000151,600,000r92,147,00047,247,000r77,963,000
Operating income-30,781,00040,765,000-203,363,000-77,231,000-29,726,000-22,528,000-24,532,000-15,578,000-20,294,000-37,332,000
Interest income (expense), net9,174,00011,765,00011,867,0003,762,000160,000271,000985,000-3,701,000-5,863,000-1,860,000
Other income (expense), net524,000329,0001,353,000r-2,872,000-2,628,000-811,000-719,000-178,000-1,031,000r-1,920,000
Total non-operating income (expense)9,698,00012,094,00013,220,000997,000-2,362,0002,778,000585,000-32,637,000-36,975,000·
Income before income taxes-21,083,00052,859,000-190,143,000-76,234,000-32,088,000-19,750,000-23,947,000-48,215,000-57,269,000-41,362,000
Income tax expense271,000310,000141,000379,000-1,426,000-1,036,000-1,979,000-1,434,000-1,709,000-1,606,000
Net income including non-controlling interests····-30,662,000-18,714,000-21,968,000-46,781,000-55,560,000-39,756,000
Net income to non-controlling interests·····00-25,000-91,000-287,000
Net income-21,354,00052,549,000-190,284,000-76,613,000-30,662,000-18,714,000-21,968,000-46,756,000-55,469,000-39,469,000
Net income to common shareholders-21,354,00052,549,000-190,284,000-76,613,000-30,662,000·····
Earnings per share, basic-0.401.00-3.54-1.44-0.59-0.40-0.52-1.31-2.38-2.39
Earnings per share, diluted-0.400.93-3.54-1.44-0.59-0.40-0.52-1.31-2.38-2.39
Weighted average shares, basic53,287,54652,773,24753,764,70553,321,62552,241,07646,481,77242,151,61735,638,95623,332,50316,496,911
Weighted average shares, diluted53,287,54656,620,59053,764,70553,321,62552,241,07646,481,77242,151,61735,638,95623,332,50316,496,911
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
us-gaap:CostOfGoodsSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton CDNA · research, not advice